116 related articles for article (PubMed ID: 16373996)
1. Telomere shortening and haemodialysis.
Boxall MC; Goodship TH; Brown AL; Ward MC; von Zglinicki T
Blood Purif; 2006; 24(2):185-9. PubMed ID: 16373996
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen metabolites: a link between oxidative stress and inflammation in patients on hemodialysis.
Samouilidou E; Grapsa E; Karpouza A; Lagouranis A
Blood Purif; 2007; 25(2):175-8. PubMed ID: 17215574
[TBL] [Abstract][Full Text] [Related]
4. Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease.
Guan JZ; Guan WP; Maeda T; Makino N
Gerontology; 2012; 58(1):62-9. PubMed ID: 21912072
[TBL] [Abstract][Full Text] [Related]
5. Telomere shortening occurs in Asian Indian Type 2 diabetic patients.
Adaikalakoteswari A; Balasubramanyam M; Mohan V
Diabet Med; 2005 Sep; 22(9):1151-6. PubMed ID: 16108841
[TBL] [Abstract][Full Text] [Related]
6. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
7. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients.
Carrero JJ; Stenvinkel P; Fellström B; Qureshi AR; Lamb K; Heimbürger O; Bárány P; Radhakrishnan K; Lindholm B; Soveri I; Nordfors L; Shiels PG
J Intern Med; 2008 Mar; 263(3):302-12. PubMed ID: 18070000
[TBL] [Abstract][Full Text] [Related]
8. Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior.
Babizhayev MA; Savel'yeva EL; Moskvina SN; Yegorov YE
Am J Ther; 2011 Nov; 18(6):e209-26. PubMed ID: 20228673
[TBL] [Abstract][Full Text] [Related]
9. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Stamatelou K; Triantafyllis G; Nicolaou C
Am J Nephrol; 2006; 26(1):91-6. PubMed ID: 16543712
[TBL] [Abstract][Full Text] [Related]
11. Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes.
Van Campenhout A; Van Campenhout C; Lagrou A; Manuel-y-Keenoy B
Biometals; 2008 Apr; 21(2):159-70. PubMed ID: 17585373
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
13. Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Am J Nephrol; 2007; 27(3):221-5. PubMed ID: 17384500
[TBL] [Abstract][Full Text] [Related]
14. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
[TBL] [Abstract][Full Text] [Related]
15. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Zoga M; Alevyzaki F; Stamatelou K; Frangou E; Savva L; Nicolaou C
Nephrology (Carlton); 2006 Dec; 11(6):506-9. PubMed ID: 17199788
[TBL] [Abstract][Full Text] [Related]
16. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
Alhamdani MS
Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
[TBL] [Abstract][Full Text] [Related]
17. Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus.
Dursun E; Dursun B; Suleymanlar G; Ozben T
Acta Diabetol; 2005 Oct; 42(3):123-8. PubMed ID: 16258735
[TBL] [Abstract][Full Text] [Related]
18. Effect of renal transplantation on endothelial function in haemodialysis patients.
Kocak H; Ceken K; Yavuz A; Yucel S; Gurkan A; Erdogan O; Ersoy F; Yakupoglu G; Demirbas A; Tuncer M
Nephrol Dial Transplant; 2006 Jan; 21(1):203-7. PubMed ID: 16144848
[TBL] [Abstract][Full Text] [Related]
19. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis.
Gritters M; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Scheffer PG; Teerlink T; Schalkwijk CG; Spreeuwenberg M; Nubé MJ
Nephrol Dial Transplant; 2006 Jan; 21(1):153-9. PubMed ID: 16144857
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
